The biology of signal transduction inhibition: Basic science to novel therapies

被引:40
作者
Griffin, J [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
关键词
D O I
10.1053/sonc.2001.29182
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3 / 8
页数:6
相关论文
共 22 条
[11]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[12]  
IKEDA H, 1991, BLOOD, V78, P2962
[13]   In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor [J].
le Coutre, P ;
Mologni, L ;
Cleris, L ;
Marchesi, E ;
Buchdunger, E ;
Giardini, R ;
Formelli, F ;
Gambacorti-Passerini, C .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (02) :163-168
[14]  
NOWELL PC, 1960, SCIENCE, V132, P1497
[15]   ARG tyrosine kinase activity is inhibited by ST1571 [J].
Okuda, K ;
Weisberg, E ;
Gilliland, DG ;
Griffin, JD .
BLOOD, 2001, 97 (08) :2440-2448
[16]   The c-terminus of c-ABL is required for proliferation and viability signaling in a c-ABL erythropoietin receptor fusion protein [J].
Okuda, K ;
D'Andrea, A ;
Van Etten, RA ;
Griffin, JD .
BLOOD, 1998, 92 (10) :3848-3856
[17]  
Okuda K, 1996, ONCOGENE, V13, P1147
[18]   NEW CONSISTENT CHROMOSOMAL ABNORMALITY IN CHRONIC MYELOGENOUS LEUKEMIA IDENTIFIED BY QUINACRINE FLUORESCENCE AND GIEMSA STAINING [J].
ROWLEY, JD .
NATURE, 1973, 243 (5405) :290-293
[19]   Mechanisms of transformation by the BCR/ABL oncogene [J].
Sattler, M ;
Griffin, JD .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (03) :278-291
[20]   Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines [J].
Weisberg, E ;
Griffin, JD .
BLOOD, 2000, 95 (11) :3498-3505